Terms: = Germ cell tumor AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551
193 results:
1. Polymer-Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme.
Du K; Li X; Feng F
ACS Appl Bio Mater; 2024 Mar; 7(3):1810-1819. PubMed ID: 38403964
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM.
Placke JM; Kimmig M; Griewank K; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Welzel J; Engel DR; Kreft S; Sucker A; Lodde G; Krefting F; Stoffels I; Klode J; Roesch A; Zimmer L; Livingstone E; Hadaschik E; Becker JC; Weichenthal M; Tasdogan A; Schadendorf D; Ugurel S
EBioMedicine; 2023 Oct; 96():104774. PubMed ID: 37660535
[TBL] [Abstract] [Full Text] [Related]
3. A novel peptide P1-121aa encoded by STK24P1 regulates vasculogenic mimicry via ELF2 phosphorylation in glioblastoma.
Li T; Liu X; Ruan X; Dong W; Liu Y; Wang P; Liu L; Tiange E; Song J; Pan A; Xue Y
Exp Neurol; 2023 Sep; 367():114477. PubMed ID: 37406957
[TBL] [Abstract] [Full Text] [Related]
4. Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution.
Kocharian G; Gobin YP; Kharas N; Knopman J; Francis JH; Abramson DH
J Neurointerv Surg; 2024 Mar; 16(4):398-404. PubMed ID: 37197934
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
Scholl JN; Weber AF; Dias CK; Lima VP; Grun LK; Zambonin D; Anzolin E; Dos Santos Dias WW; Kus WP; Barbé-Tuana F; Battastini AMO; Worm PV; Figueiró F
Purinergic Signal; 2024 Feb; 20(1):47-64. PubMed ID: 36964277
[TBL] [Abstract] [Full Text] [Related]
6. CD73 in glioblastoma: Where are we now and what are the future directions?
Gelsleichter NE; Azambuja JH; Rubenich DS; Braganhol E
Immunol Lett; 2023; 256-257():20-27. PubMed ID: 36958430
[TBL] [Abstract] [Full Text] [Related]
7. Dual [
Chan DL; Hayes AR; Karfis I; Conner A; Furtado O'Mahony L; Mileva M; Bernard E; Roach P; Marin G; Pavlakis N; Schembri G; Gnanasegaran G; Marin C; Vanderlinden B; Navalkissoor S; Caplin ME; Flamen P; Toumpanakis C; Bailey DL
Br J Cancer; 2023 Feb; 128(4):549-555. PubMed ID: 36434154
[TBL] [Abstract] [Full Text] [Related]
8. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
9. [Analysis of three Chinese pedigrees affected with recurrent hydatidiform mole due to variants of NLRP7 gene].
Shen J; Gao Y; Wu W; Liu J; Sun X; Peng Y; Xie J; Wang D; Cui Y; Liu J; Diao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Oct; 39(10):1070-1075. PubMed ID: 36184085
[TBL] [Abstract] [Full Text] [Related]
10. In-Vitro Use of Verteporfin for Photodynamic Therapy in Glioblastoma.
Jeising S; Geerling G; Guthoff R; Hänggi D; Sabel M; Rapp M; Nickel AC
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103049. PubMed ID: 35932958
[TBL] [Abstract] [Full Text] [Related]
11. Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma.
Coleman S; Xie M; Tarhini AA; Tan AC
Mol Carcinog; 2023 Jan; 62(1):77-89. PubMed ID: 35781709
[TBL] [Abstract] [Full Text] [Related]
12. PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and tumor Progression.
Kreße N; Schröder H; Stein KP; Wilkens L; Mawrin C; Sandalcioglu IE; Dumitru CA
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682709
[TBL] [Abstract] [Full Text] [Related]
13. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract] [Full Text] [Related]
14. Personalized functional profiling using
Kim H; El-Khoury V; Schulte N; Zhan T; Betge J; Cousin L; Felli E; Pessaux P; Ogier A; Opitz O; Ku B; Ebert MP; Kwon YJ
Cancer Biol Ther; 2022 Dec; 23(1):96-102. PubMed ID: 35193475
[TBL] [Abstract] [Full Text] [Related]
15. Multifunctional liposome for photoacoustic/ultrasound imaging-guided chemo/photothermal retinoblastoma therapy.
Li M; Bian X; Chen X; Fan N; Zou H; Bao Y; Zhou Y
Drug Deliv; 2022 Dec; 29(1):519-533. PubMed ID: 35156504
[TBL] [Abstract] [Full Text] [Related]
16. Quadruplet Pregnancy with Complete Mole and Three Viable Fetuses.
Yener C; Sayın NC; Keskin FEU; Altan E; Ateş S; Varol F
Fetal Pediatr Pathol; 2022 Dec; 41(6):1035-1040. PubMed ID: 34807794
[No Abstract] [Full Text] [Related]
17. Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial.
Krug S; Kegel T; Gress TM; Rinke A; Apostolidis L; Jann H; König A; Hörsch D; Schrader J; Ettrich TJ; Richter M; Steighardt J; Michl P
BMC Cancer; 2021 Nov; 21(1):1206. PubMed ID: 34772353
[TBL] [Abstract] [Full Text] [Related]
18. High Relative Biological Effectiveness of 2 MeV Fast Neutrons for Induction of Medulloblastoma in Ptch1+/- Mice with Radiation-specific Deletion on Chromosome 13.
Tsuruoka C; Kaminishi M; Shinagawa M; Shang Y; Amasaki Y; Shimada Y; Kakinuma S
Radiat Res; 2021 Aug; 196(2):225-234. PubMed ID: 34046685
[TBL] [Abstract] [Full Text] [Related]
19. NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK cells.
Vicioso Y; Wong DP; Roy NK; Das N; Zhang K; Ramakrishnan P; Parameswaran R
Front Immunol; 2021; 12():652786. PubMed ID: 33995369
[TBL] [Abstract] [Full Text] [Related]
20. Postmenopausal exogenous hormone therapy and Melanoma risk in women: A systematic review and time-response meta-analysis.
Tang X; Zhang H; Cui Y; Wang L; Wang Z; Zhang Y; Huo J; Cai J; Rinaldi G; Bhagavathula AS; Xiaopeng Y
Pharmacol Res; 2020 Oct; 160():105182. PubMed ID: 32890740
[TBL] [Abstract] [Full Text] [Related]
[Next]
